Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.096 EUR | +8.12% |
|
+8.18% | -61.81% |
26/06 | EyePoint Pharmaceuticals, Inc. Highlights Duravuyu Clinical and Regulatory Progress and Pipeline Innovation At R&D Day 2024 | CI |
26/06 | Transcript : EyePoint Pharmaceuticals, Inc. - Special Call |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- EYPT Stock
- PV3B Stock
- Revisions EyePoint Pharmaceuticals, Inc.